FDA NDC Directory · JSON-LD · Markdown

SAMSCA

NDC 59148-021 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nametolvaptan
Labeler / ManufacturerOtsuka America Pharmaceutical, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022275
Dosage form / routeTABLET · ORAL
Active ingredientsTOLVAPTAN (30 mg/1)
Marketing started20090519
Package count1

External sources

Source: openFDA. Public-domain (CC0).